Active maintenance of genome stability is a prerequisite for the development and function of the nervous system. The high replication index during neurogenesis and the long life of mature neurons highlight the need for efficient cellular programs to safeguard genetic fidelity. Multiple DNA damage response pathways ensure that replication stress and other types of DNA lesions, such as oxidative damage, do not affect neural homeostasis. Numerous human neurologic syndromes result from defective DNA damage signaling and compromised genome integrity. These syndromes can involve different neuropathology, which highlights the diverse maintenance roles that are required for genome stability in the nervous system. Understanding how DNA damage signaling pathways promote neural development and preserve homeostasis is essential for understanding fundamental brain function.
r e v i e w
The genesis of the nervous system requires an enormous expansion of highly proliferative neuroepithelium that generates a diverse array of long-lived cell types. Among these are specialized neurons that fulfill functionally diverse roles in information processing and signal integration. Equally important are non-neuronal populations of glial cells that provide metabolic and functional support for the nervous system 1, 2 . A central aspect of neural homeostasis is the need to maintain genomic integrity after damage to DNA during normal cellular activity or during DNA replication. Indeed, DNA damage in the form of double-stranded breaks can arise spontaneously in the brain as a result of neuronal activity 3 . Age-related accumulation of DNA damage in the brain can also affect gene expression, which potentially affects processes involving memory and neuronal survival 4 . More directly, many inherited human syndromes that arise from mutations affecting genome stability are characterized by neuropathology, revealing critical roles for DNA damage surveillance and repair in safeguarding the nervous system 5 .
The specific requirements for genome maintenance can change substantially in the transition from neurogenesis to nervous system maturation ( Fig. 1) . During neurogenesis, a prime source of DNA damage occurs during replication. The genomes of differentiated neural cells, which populate the nervous system for the life of an organism, must be protected against continual DNA damage. This damage can result, for example, from exposure to reactive chemical species such as those produced by oxidative metabolism or from transcription-associated breaks. Thus, at multiple levels throughout the development and maintenance of the nervous system, there is a constant need to ensure genome integrity. The following sections detail how the many biochemically distinct DNA repair pathways maintain genome integrity during neurodevelopment and in the mature nervous system. Underscoring this is consideration of a variety of human diseases that illustrate how defective DNA damage signaling affects the nervous system.
Multiple DNA repair pathways function in the nervous system In broad terms, the nervous system can be divided into two different phases that require different cellular strategies to ensure genome integrity. During early development, neurogenesis is driven by proliferation, and the high replicative rate of neural progenitors is associated with replication-associated DNA damage 5 . Similar to other organs, the nervous system contains the full repertoire of DNA repair pathways. Individually, these distinct biochemical pathways respond to specific types of DNA lesions, such as DNA single-or double-stranded breaks or DNA crosslinks. The biochemical details of each of the main DNA repair pathways have recently been comprehensively reviewed [6] [7] [8] [9] [10] [11] [12] [13] and, in the interest of space, a detailed outline will not be presented.
Importantly, different types of DNA lesions are corrected by specific biochemical repair pathways. For instance, bulky, helixdistorting lesions such as those induced by ultraviolet radiation are repaired by the nucleotide excision pathway (NER) 12 , whereas DNA double-stranded breaks can undergo repair by either homologous recombination or non-homologous end-joining (NHEJ) 7 . DNA doublestranded breaks are particularly hazardous to the cell, as they can activate apoptosis or lead to mutagenic rearrangements. Homologous recombination requires an available sister chromatid to facilitate error-free repair, which means that this process occurs during S or G2 phase of the cell cycle, whereas NHEJ, which involves direct ligation of processed ends of the DNA break, can occur at any stage of the cell cycle 7, 10 . In contrast, the more common lesion of a DNA singlestranded break is repaired via the XRCC1-mediated base excision repair (BER)/single-stranded break repair pathway 6 . Other pathways that are important include those that repair interstrand crosslinks and the mismatch repair pathway, which corrects mismatched bases that can form during DNA replication 8, 11 . These repair pathways are important in the nervous system, as defects in any of these can have a detrimental effect on many facets of neural function 5 . For instance, perturbation of NHEJ can result in neurodevelopmental defects 14, 15 and faulty nucleotide excision repair can lead to neurodegeneration or 5, [16] [17] [18] . In the case of DNA single-stranded breaks, repair defects can lead to neurodegenerative disease 5, 6 . An overview of representative neurologic diseases that result from various defects in DNA damage responses is presented in Table 1 .
In addition to key information from inherited human syndromes 5, 6, 19 , the importance of specific DNA repair pathways during neural development has also been directly shown using gene targeting in mice to disrupt gene function. For example, inactivation of DNA double-stranded break repair factors involved in homologous recombination or NHEJ, or components of the BER pathway, have a profound effect on neural development [20] [21] [22] [23] [24] [25] . Neural progenitors at different stages of differentiation and commitment have a selective sensitivity toward DNA damage whereby the early-born cortical progenitors are hypersensitive to replication-associated DNA damage 26 . Neural signaling responses to genome insults can also vary depending on cellular differentiation status and tissue type 26, 27 . These differences in susceptibility to DNA damage may reflect the varied neuropathology characteristic of DNA repair deficiency diseases.
DNA integrity during development is also maintained by the coordinated signaling of pathways that respond to DNA damage by pausing cell proliferation to allow DNA repair or, alternatively, by the activation of apoptosis to eliminate damaged cells and avoid the potential acquisition of mutations. Elimination of progenitors with excessive DNA damage may be a preferred option in some cases, particularly as the nervous system is known to use apoptosis during normal neural development to eliminate over-produced cells 28, 29 . However, after cessation of neurogenesis, DNA repair is still of paramount importance for guarding the genome throughout the life of the nervous system.
Neural homeostasis in mammals relies on a post-mitotic nervous system that requires constant DNA repair activity during the life of this tissue. The types of DNA damage in non-cycling cells can be different to those encountered during development, as are the pathways available for DNA repair (Fig. 1) . For example, in non-cycling cells, homologous recombination is unavailable to repair DNA doublestranded breaks. In post-mitotic neurons, NHEJ is the sole pathway available to prevent accumulation of DNA double-stranded breaks 30 . Accordingly, in the absence of a key NHEJ component, DNA ligase IV, neurons progressively accumulate endogenous double-stranded breaks, indicating the essential nature of this pathway for preventing DNA damage in the mature nervous system 30 Figure 1 Different DNA repair pathways function during neural development. Neural development encompasses widespread proliferation, migration and differentiation that generate the neurons and glia of the adult nervous system. At different stages of development, the nervous system is susceptible to different types of DNA damage. During proliferation, replication-associated DNA strand breaks can occur that may require DNA double-stranded break repair (DSBR), which involves either homologous recombination (HR) or NHEJ. Mismatch repair (MMR) is also important for correcting base incorporation errors that occur during replication. Homologous recombination is dependent on using replicated sister chromatids as an error-free repair template, and this pathway is therefore not available in non-replicating or differentiated cells. Replicating cells may also incur other types of damage, including inter-strand crosslinks or strand breaks from other sources, including oxidative lesions and transcription-associated damage. In non-cycling cells, NHEJ repairs DNA double-stranded breaks, whereas other types of DNA damage require the BER/ single-stranded break repair (SSBR) pathway or NER. An alternate outcome to DNA damage in replicating and immature, non-differentiated neural cells is apoptosis, whereas DNA lesions in differentiated cells do not activate apoptosis, but can instead interfere with transcription. Neurodevelopmental microcephaly a Biallelic mutations in the homologous recombination factor BRCA2 occurs in a subgroup of Fanconi anemia, highlighting the connections between homologous recombination and crosslink repair. b The BER pathway is based on an Xrcc1-mediated processes, which includes single-stranded break repair. c This pathway utilizes components of homologous recombination (for example, BRCA2). d Neurodegeneration is only present in some cases of xeroderma pigmentosum and is related to the specific NER component that is mutated. e Microcephaly is characteristic of Nijmegen breakage syndrome, although specific mutations in MRE11 result in microcephaly rather than ATLD 34 . f Seckel syndrome can arise from defects in the ATR DNA damage-signaling pathway or from defects in the centrosome and shares phenotypic and genetic overlaps with primary microcephaly disorders that arise from centrosome defects.
r e v i e w DNA damage signaling is required for neural development Coincident with DNA processing and repair are distinct signaling pathways that become activated following DNA damage. These genome surveillance pathways activate cell cycle arrest to pause proliferation and allow for DNA repair or to ensure genome stability by initiating apoptosis to eliminate damaged cells. The critical role of DNA damage signaling in the nervous system is fulfilled by the DNA damage-activated kinases ATM (ataxia telangiectasia, mutated) and ATR (ATM and Rad3 related) (Fig. 2) . ATR and ATM have largely separate roles in maintaining genome stability in the nervous system 31 . These distinct kinases are activated by different types of DNA damage; DNA double-stranded breaks are detected by the MRN (MRE11-RAD50-NBS1) complex, which promotes autophosphorylation and activation of ATM, leading to the subsequent phosphorylation of specific ATM substrates, to initiate cell cycle arrest or apoptosis of immature neural cells 23, 32, 33 . DNA damage-induced apoptosis may be a central function of this kinase in the nervous system 27, 34 . This pathway is critical in the nervous system, as loss of ATM results in the childhood neurodegenerative syndrome ataxia telangiectasia 32, 34 . Similarly, mutation of components of the MRN complex can lead to an ataxia telangiectasia-like disease (ATLD), in the case of certain MRE11 mutations, or Nijmegen breakage syndrome (NBS) after NBS1 mutation, which is characterized by microcephaly [35] [36] [37] . The MRN complex is also essential for homologous recombination 38 , indicating that the disease-causing mutations that are responsible for the development of ATLD or NBS are hypomorphic, which means that they allow cell replication to proceed. In contrast with ATM, the related ATR kinase is central for signaling DNA replication stress and responds to replication protein A-coated single-stranded DNA, a common lesion formed during replication fork collapse 39 . ATR is critical for preventing ATRSeckel syndrome, a neurodevelopmental disease that occurs as a result of hypomorphic mutations in this gene 40, 41 . In this way, these two kinases function, largely independently, to address common types of DNA damage that occur during neural development (Fig. 2) .
Neurogenesis and susceptibility to DNA damage Neural progenitors are particularly sensitive to DNA damage and their relative susceptibility can vary depending on the stage of development. For example, Topoisomerase II binding protein 1 (TopBP1), which is essential for maintaining DNA integrity during replication 42 and is an important activator of the DNA damage response kinase ATR (Fig. 2) , is critical for the survival of early-born neural progenitors 26 . Mice in which Topbp1 was inactivated in early cortical progenitors using Emx1-cre showed substantial neurodevelopmental abnormalities throughout the cortex that resulted from widespread apoptosis of newborn progenitors 26 . Notably, when TopBP1 was deleted in later stage cortical progenitors using Nes-cre, cortical progenitor loss was markedly reduced; this was despite the deletion of Topbp1 by either Nes-cre or Emx1-cre resulting in similar amounts of DNA damage in embryonic day 13.5 (E13.5) neural progenitors 31 . Thus, the striking difference in cortical phenotype after deletion via the different Cre drivers is not a result of different amounts of DNA strand breaks, but rather the enhanced susceptibility of earlier-born cortical progenitors to DNA damage after TopBP1 loss. This enhanced sensitivity of earlier progenitors to DNA damage may indicate a lower threshold for apoptosis compared with those progenitors generated at later developmental stages. The propensity for apoptosis after DNA damage in very early progenitors is a preferred way to maintain genome integrity rather than risk progenitor expansion with misrepaired DNA 43 . Differential susceptibility of progenitors to DNA damage at different stages of cellular differentiation may be linked to cell cycle dynamics, an important feature that characterizes the changing properties of neural progenitors. Cell-cycle regulation of neural progenitors is a key aspect of cortical development and involves dynamic changes in G1 phase and S phase duration [44] [45] [46] [47] . The length of these cell-cycle phases are linked to progenitor proliferation compared with differentiation, as G1 phase lengthening is associated with differentiating progenitors (Fig. 3) . A key difference between proliferating and neurogenic progenitors is the length of S phase; an approximately threefold longer S phase is characteristic of neural progenitor expansion compared with progenitors committed to the neurogenic lineage 44 . This suggests that S phase duration is an important determinant of proliferative capacity of cortical progenitors. Proliferative progenitors that are not lineage-restricted likely have a greater need for repair of DNA replication-associated damage to avoid transmission of genetic errors during early progenitor expansion.
In addition, recent findings indicate that chromatin state is important for the neurogenic potential of cortical progenitors 48 . Chromatin accessibility is likely an important feature of early progenitors before neurogenic division and may be critical for rapid proliferation and the undifferentiated state. An important mediator of chromatin condensation npg r e v i e w in cortical progenitors is the high mobility group A proteins, which promote chromatin opening by competitive interaction with histone H1 49, 50 . Correspondingly, Hmga1 levels are increased in cortical progenitors during neurogenesis, and the presence of this protein can regulate neurogenic potential in these cells 48 . Chromatin state is also an important determinant of the DNA damage response and DNA repair 26, [51] [52] [53] [54] [55] [56] . More generally, regulation of chromatin structure is a key feature of neural development and later function of the nervous system [57] [58] [59] [60] . How chromatin state directly affects DNA damage signaling in neural during development and in the mature brain is not yet clear, but will undoubtedly affect aspects of neural genome stability.
Genome stability in the mature nervous system Genome stability mechanisms in the mature nervous system differ with those during neurogenesis because of the lack of cell division and the absence of replicative DNA damage and repair via homologous recombination (Fig. 1) . For instance, DNA damage in the mature nervous system can involve DNA breaks arising from oxidative stress, which may perturb cellular homeostasis or affect transcription [61] [62] [63] [64] . Furthermore, as opposed to proliferating and immature neural cells that are proficient for DNA damage-induced apoptosis 43 , differentiated cells do not typically engage apoptosis after DNA damage 65, 66 .
In addition, there are many non-neuronal cells in the mature nervous system, and the responses to DNA damage in these are likely similar to those of neurons. Studies using cortical astrocytes clearly show that these cells mount a normal DNA damage response 26, 31 . DNA damage is also strongly linked to aging and cognitive decline, processes that highlight the effect in the mature brain of accumulating DNA lesions that may arise from attenuated DNA repair processes 17 . Oxidative DNA damage is a primary consideration, as the brain metabolizes 20% of all consumed oxygen 67 , a substantial portion of which is required for basic cellular house-keeping functions in addition to synaptic and cognitive functions 68 . Key lesions that affect the mature brain are breaks in one strand of DNA, termed DNA single-stranded breaks. This type of damage is repaired by either the XRCC1-dependent single-stranded repair pathway/BER or by transcription-coupled repair, a component of the nucleotide excision pathway 12, 18, 62 . The relevance of single-stranded break repair in the brain is highlighted by multiple neurologic syndromes arising from inherited defects in components of this pathway (Fig. 4) . This lesion is considered to be the most common insult to DNA in the cell and somewhere in the order of 1,000 breaks may occur per cell per day 6 . The close relationship between oxidative stress and DNA strand breaks in the nervous system was shown by suppression of DNA damage in mice with disabled NHEJ repair after reduction of the cellular oxygen tension, or the increase in breaks by overexpressing the antioxidant enzyme superoxide dismutase 69 . An additional source of endogenous DNA double-stranded breaks may arise via normal topoisomerase-II-beta function during transcription 70 . These sitespecific transcription-associated DNA breaks localize to gene promoters, involve components of the DNA repair machinery and may contribute to accumulated DNA damage found in the aged brain 4 .
One notable feature of the mature nervous system is ongoing neurogenesis in certain brain regions, including the lateral ventricle and the hippocampus 71, 72 . Recent data indicate that adult hippocampal neurogenesis occurs at the rate of 700 new neurons per day (around a 1.75% turnover), suggesting that this ongoing process is an important feature of hippocampal function 73 . These new hippocampal neurons will also require genome maintenance during proliferation, and will therefore be competent for homologous recombination and other DNA damage response pathways typical of neurogenesis.
Neurologic disease results from loss of genome stability It is clear from the varied neuropathology present in multiple DNA repair-deficient human syndromes that the nervous system is highly Figure 4 Defective DNA single-stranded break repair can result in syndrome with varied neuropathology. Single-stranded breaks are a frequent type of DNA lesion in the nervous system. These lesions are repaired by an XRCC1-mediated pathway that includes polymerase β and ligases to complete repair after end-processing factors process damaged DNA termini to facilitate ligation. Factors such as TDP1 process 3′ termini and APTX processes 5′ lesions involving adenylation of DNA, whereas PNKP can process both 5′ and 3′ termini. Defects in APTX and TDP1 lead to human neurodegeneratiove syndromes, whereas disruption of PNKP leads to microcephaly rather than neurdegeneration. Notably, despite these factors participating in the same DNA repair pathway, the resultant neuropathology is distinct.
npg r e v i e w susceptible to different types of DNA damage ( Table 1) . These syndromes can affect different brain regions and the nervous system at different developmental times, resulting in a spectrum of neuropathology spanning neurodegeneration, neurodevelopmental disorders or brain tumors 5 . As discussed, replication-associated damage is a prime source of DNA lesions during neurogenesis and contributes to defects leading to neurodevelopmental syndromes. In the mature brain, the high oxygen consumption and free radicals produced by cellular metabolism can lead to abundant single-stranded breaks, which can compromise genetic integrity and perturb cellular homeostasis, leading to interference with transcription 6, 18 . Defects in any of the steps involved in responding to these types of damage can result in syndromes marked by neurologic disease 5, 6 .
Although identification of the gene mutation responsible for a disease will indicate the affected DNA repair pathway, this alone may not necessarily be sufficient to explain the resultant neuropathology. For example, defects in individual components of DNA single-stranded break repair might be expected to result in similar phenotypes. Three distinct diseases that result from defective single-stranded break repair are ataxia with oculomotor apraxia 1 (AOA1), in which the nucleotide hydrolase Aprataxin (APTX) is defective, spinocerebellar ataxia with axonal neuropathy 1 (SCAN1), in which tyrosyl-DNA phosphodiesterase 1 is mutated, and microcephaly with seizures (MCSZ), which results from mutations in polynucleotide kinase/phosphatase (PNKP) [74] [75] [76] [77] . APTX processes 5′ adenylation intermediates 78 , TDP1 cleaves topoisomerase-1-DNA complexes and can resolve oxidative DNA lesions 6 , and the dual 5′kinase/3′phosphatse activity of PNKP restores the ends of a DNA strand break for ligation (Fig. 4) 79 .
The phenotype of AOA1 and SCAN1 are characterized by spinocerebellar ataxia and neurodegeneration, although the onset of AOA1 is early, around 2-4 years, whereas SCAN1 onset occurs in the teenage years [75] [76] [77] . In addition, both syndromes show cerebellar atrophy and progressive degenerative changes, including peripheral neuropathy, although AOA1 manifests oculomotor apraxia, whereas this defect is not present in SCAN1. One complication that arises when directly comparing these syndromes is the limited number of SCAN1 individuals that have been identified, as this disease has currently been linked to multiple individuals from a single family, whereas AOA1 is a common recessive ataxia in certain geographical areas [75] [76] [77] . In contrast with AOA1 and SCAN1, MCSZ is neurodevelopmental rather than neurodegenerative 74 . In this disease, the function of PNK is severely compromised as a result of hypomorphic PNKP mutations and an associated reduction in protein levels, which leads to a DNA repair defect 80 . Thus, despite faulty end-processing of DNA damage underlying these diseases, the phenotypes are quite distinct, raising the question of why there are such differences between these syndromes.
Given that these disease phenotypes correlate with the relative requirements for each factor in processing DNA damage, and that all three factors interact with XRCC1, a central scaffolding protein that enhances the relative repair rate of SSBs 6 , then it may be that the lesions that require APTX occur more frequently than those dependent on TDP1 for repair. In general, the differences are unlikely to reflect tissue specificity, as cerebellar dysfunction underpins the age-related cerebellar ataxia in both syndromes [75] [76] [77] . However, other differences between AOA1 and SCAN1, such as oculomotor apraxia, may involve tissue-specific utilization of each DNA repair factor. With regard to PNKP, the 3′-phosphatase activity of this enzyme is critical for global rates of single-stranded break repair, and a high percentage of this type of break after endogenous oxidative stress will utilize PNKP 79, 81 . This predicts that the loss of PNKP would result in heightened DNA repair deficiency than loss of either APTX or TDP1 and a worsened neurodegenerative phenotype than AOA1 or SCAN1. Because MCSZ results in pronounced microcephaly at birth, this may indicate a higher relative importance for the PNKP repair functions associated with increased DNA damage during neurogenesis. In addition, given that PNKP has also been linked to DNA double-stranded break repair 79 and that defects in this pathway can also lead to microcephaly 82 , perhaps the main developmental function for PNKP is repair of this lesion. Thus, the small brain size in MCSZ may result from DNA double-stranded break-induced apoptosis during development 5 . However, this explanation is not easy to reconcile because deficiency in the repair of DNA double-stranded breaks affects tissues outside of the nervous system and this is not the situation with MCSZ 74 . The ongoing development of mouse models for these and other diseases will provide important reagents for determining the molecular basis for the different neurologic phenotypes resulting from various DNA lesions.
Centrosomes, genome stability and neurologic disease Multiple microcephaly syndromes have been identified in which the targets of the developmental defects are cortical progenitors, and functional analysis of the gene product in these syndromes strongly implicates the centrosome 83, 84 . Intriguingly, related syndromes that are also characterized by microcephaly and neurodevelopmental abnormalities arise directly from mutation of DNA damage response factors such as ATR 40, 41 . Furthermore, mutations in the centrosomal factor pericentrin can result in Seckel syndrome, which is associated with defective DNA damage signaling 85 . Collectively, these findings suggest that there is an important connection between the DNA damage response and the centrosome.
The centrosome is an important cellular organelle in cortical progenitors, as it can regulate migration and cellular division symmetry, which is an important determinant in symmetric versus neurogenic division [86] [87] [88] . Recent data has shown that centrosomes can also integrate cell cycle checkpoints and DNA repair after genotoxic stress 83, 85, [89] [90] [91] . In addition, key DNA damage response factors, such as ATR and NBS1, and cell cycle checkpoint factors, Chk1 and Chk2, can localize to centrosomes after DNA damage to effect cell cycle arrest and modulate mitosis 83, 86, 90, 92 . In Seckel syndrome arising from specific mutations of ATR (ATR-Seckel syndrome) or centrosomal protein 152 (CEP152; SCKL5), supernumery centrosomes were found after ATR dysfunction and defective DNA damage signaling was observed when CEP152 function was compromised 40, 41, 92 . Thus, a connection is apparent between the DNA damage response, centrosome function and microcephaly. Understanding how the DNA damage response interfaces with centrosome function and neural development will be important for understanding the genesis of human microcephaly and other related neurodevelopmental disorders.
Mitochondrial genome stability in the nervous system In addition to the nuclear genome, there is also the ~16-kb circular mitochondrial genome, which is also susceptible to DNA damage. Although DNA damage and repair occurs in mitochondria, the mitochondrial genome may be most susceptible to replication defects. Faulty mtDNA replication, such as that resulting from germline mutations of DNA polymerase γ (POLG), can lead to a wide spectrum of clinically distinct syndromes, many of which affect the nervous system 93 . In particular, the diversity of different phenotypes, including multiple neurologic diseases that result from specific point mutations in POLG, illustrate the striking outcomes of defective mtDNA replication 94 . These replication defects affect Active mtDNA repair processes have been extensively demonstrated by cellular studies 95 , as has the mitochondrial localization of key BER/single-stranded break repair factors, including those linked to neurodegenerative disease such as Aprataxin 96 . Thus, defective mtDNA repair may contribute to the phenotype of neurodegenerative diseases 95 . Moreover, there is a mitochondrial-specific version of DNA ligase III that can participate in mtDNA replication and repair. Inactivation of this DNA ligase in the nervous system leads to a profound postnatal loss of cerebellar granule neurons and neuraxis-wide defects, which results in pronounced ataxia, underscoring the paramount importance of mtDNA integrity for neural function 97 .
However, given that there can be hundreds of individual mitochondria in a cell, mtDNA repair deficiency (if damage is stochastic) will sporadically affect individual mitochondria, and the subsequent cellular effect is not as obvious as general mtDNA replication defects. In addition, the presence of mitochondrial fusion as a means of safeguarding mtDNA integrity 98 suggests that there are additional strategies for preventing adverse effects from mitochondrial genome disruption. Nonetheless, the existence of mtDNA repair capacity suggests that this process is important for mitochondrial homeostasis, and associated defects in mtDNA repair could exacerbate the neurodegenerative phenotypes in human DNA repairdeficient syndromes.
Perspectives and conclusions
The occurrence of DNA damage is a feature of nervous system development and maintenance and an armamentarium of DNA repair factors exist to prevent this damage from persisting and having pathogenic consequences. Human DNA repair deficiency syndromes provide direct examples of the need for vigilant DNA repair processes, which are needed to resolve multiple types of DNA damage. Furthermore, the effect on the nervous system in these syndromes provides critical insight as to how specific DNA repair factors are used throughout this tissue. However, many key questions remain unanswered regarding the outcomes of defective DNA damage signaling in the nervous system. For example, disruption of DNA doublestranded break repair generally results in neuropathology, but also includes more general systemic defects, whereas disruption of DNA single-stranded break repair leads to pathology that mostly, if not exclusively, involves the nervous system. Furthermore, the manner in which dysfunction of these DNA repair pathways lead to different pathology, such as neurodegeneration compared with microcephaly, remains unclear.
The prevalence of endogenous DNA damage throughout the neuraxis also raises the specter of DNA damage contributing to pathology in other neurologic syndromes. DNA damage has been considered a likely contributing factor in Parkinson's and Alzheimer's disease 99, 100 , and DNA double-stranded break repair deficiency was recently found to exacerbate the effects of amyloid precursor protein in the context of Alzheimer's disease, with a potential effect on synaptic function 3 . It will be important to determine whether DNA lesions affect other neurologic syndromes and whether these lesions occur as collateral damage during disease processes. Understanding how DNA damage affects the nervous system will be essential for developing appropriate therapeutics that can prevent damage or enhance functionality of the DNA damage response pathways.
